Prevent Blindness has existed for more than a century with one clear mission: to prevent blindness and preserve sight. The organization focuses on eye health conditions in the US, working to improve both education and public policy.
“Partnerships with the industry and biotech companies like Oxurion are crucial to us,” says Jeff Todd, President & CEO. “It is vital that ophthalmologists, retina specialists, patient organizations, R&D companies and the big pharma industry work together to have an impact on a large scale. It will take all of us to fight blindness and sight-threatening diseases.”
“Visual disorders have a large impact on the patient’s life,” he continues. “Not being able to drive a car or go to work makes them lose their independence. That is definitely an aspect Prevent Blindness is strongly focusing on. We want to make sure people have a high quality of life, not impacted by visual problems.”
To fulfil its mission, Prevent Blindness wants to partner with organizations that are trying to solve problems currently lacking a treatment or looking for ways to improve an existing one. “That is why we’re so excited to partner with Oxurion. They have an innovative approach to new eye care research for conditions that presently have no known therapies. Their cutting-edge research can really improve and change people’s lives,” concludes Jeff Todd.